Stay updated on CIN-107 Study in Uncontrolled Hypertension Clinical Trial

Sign up to get notified when there's something new on the CIN-107 Study in Uncontrolled Hypertension Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CIN-107 Study in Uncontrolled Hypertension Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the systolic blood pressure (SBP) lowering efficacy of baxdrostat (CIN-107) in patients with uncontrolled hypertension after 8 weeks of treatment.
    Difference
    0.1%
    Check dated 2024-06-06T14:24:44.000Z thumbnail image
  5. Check
    7 days ago
    No Change Detected
  6. Check
    18 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participation in the study, specifying health conditions and prior treatments required for inclusion. It also outlines specific exclusion criteria and provides general information about clinical research.
    Difference
    19%
    Check dated 2024-05-22T20:31:20.000Z thumbnail image
  7. Check
    40 days ago
    Change Detected
    Difference
    1.0%
    Check dated 2024-04-30T22:35:25.000Z thumbnail image

Stay in the know with updates to CIN-107 Study in Uncontrolled Hypertension Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CIN-107 Study in Uncontrolled Hypertension Clinical Trial page.